-5%
Neurocet XR’s precise mechanism of action is not fully understood. It works by inhibiting burst firing in the hippocampus without affecting normal neuronal excitability, potentially preventing the hyper-synchronization of epileptiform bursts and the propagation of seizures.
Neurocet XR is indicated for the treatment of various types of seizures and epilepsy:
- Monotherapy:
- For the treatment of partial-onset seizures (with or without secondary generalization) in adults and adolescents (16 years and older) with newly diagnosed epilepsy.
- Adjunctive therapy:
- For partial-onset seizures (with or without secondary generalization) in adults, adolescents, children, and infants (from 1 month of age).
- For myoclonic seizures in adults and adolescents (12 years and older) with Juvenile Myoclonic Epilepsy.
- For primary generalized tonic-clonic seizures in adults and adolescents (12 years and older) with Idiopathic Generalized Epilepsy.